Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1751Urinary Bladder Neoplasms 351Carcinoma, Renal Cell 217Breast Neoplasms 209Neoplasms 164Kidney Neoplasms 157Lung Neoplasms 101Colorectal Neoplasms 95Motor Activity 85Testicular Neoplasms 59Ovarian Neoplasms 52Colonic Neoplasms 48Melanoma 47Pancreatic Neoplasms 44Neoplasm Metastasis 43Non-Muscle Invasive Bladder Neoplasms 42Urinary Incontinence 40Head and Neck Neoplasms 40Uterine Cervical Neoplasms 39Carcinoma, Transitional Cell 39Disease 38Urologic Neoplasms 36Sarcoma 36Recurrence 35Anxiety Disorders 31Stomach Neoplasms 29Carcinoma, Non-Small-Cell Lung 29Lymphoma 28Endometrial Neoplasms 28Prostatic Hyperplasia 27

Interventions

sulforaphane 1Gelatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Prostate Cancer Prevention × Genitourinary × Clear all
NCT01265953 2019-05-01

PBroC

Portland VA Medical Center

Phase NA Completed
98 enrolled 10 charts
Genitourinary

Prostate Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡